EN | UA
EN | UA

Help Support

Back

Minoxidil-Spironolactone vs. Minoxidil-Finasteride for treatment of AGA, FPHL, and MPHL

Alopecia Alopecia
Alopecia Alopecia

A blinded randomized clinical trial aimed to evaluate the impact of topical Minoxidil plus oral Spironolactone, as opposed to the topical Minoxidil plus oral Finasteride in women battling with androgenetic alopecia (AGA), female pattern hair loss (FPHL), and male pattern hair loss (MPHL).

Source:

Journal of Cosmetic Dermatology

Article:

The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial

Authors:

Afsaneh Sadeghzadeh Bazargan et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: